| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/18/2012 | CN102319222A Decitabine freeze-dried preparation and preparation method thereof |
| 01/18/2012 | CN102319219A Chitosan nanoparticle preparation of ceftiofur sodium, and preparation method thereof |
| 01/18/2012 | CN102319218A Drug sustained and controlled release microparticle preparation for treating intestinal diseases, and preparation method thereof |
| 01/18/2012 | CN102319217A Polysaccharide coated magnetic nano-particle and preparation method |
| 01/18/2012 | CN102319215A Vecuronium bromide liposome injection |
| 01/18/2012 | CN102319214A Lipid microsphere injection containing sodium demethyl cantharidate-phosphatide complex and preparation method thereof |
| 01/18/2012 | CN102319213A Beraprost acid nanolipid microsphere preparation |
| 01/18/2012 | CN102319212A Clevidipine butyrate structured lipid emulsion and preparation method thereof |
| 01/18/2012 | CN102319210A Veterinary long-acting cefquinome sulfate injection and preparation method thereof |
| 01/18/2012 | CN102319208A Suspension composition for treating oral mucositis caused by chemoradiotherapy |
| 01/18/2012 | CN102319207A 42-(dimethylphosphinate) rapamycin liquid composition |
| 01/18/2012 | CN102319206A Stable aqueous solution of recombinant human interleukin-11, and preparation method thereof |
| 01/18/2012 | CN102319205A Ibuprofen injection and preparation method thereof |
| 01/18/2012 | CN102319204A Azithromycin ophthalmic preparation drug composition and preparation method thereof |
| 01/18/2012 | CN102319203A Preparation method of levofloxacin lactate and sodium chloride injection |
| 01/18/2012 | CN102319202A Mometasone furoate gel and preparation method thereof |
| 01/18/2012 | CN102319201A Drug transfer printing process |
| 01/18/2012 | CN102078483B Chinese patent medicine (Bezoar Qianliekang Turunda) for treating prostate disease and preparation method thereof |
| 01/18/2012 | CN102018668B Preparation method of aceglutamide |
| 01/18/2012 | CN101940745B Jinji blood stasis eliminating particles and preparation method thereof |
| 01/18/2012 | CN101926756B Solid preparation of clopidogrel or pharmaceutically acceptable salt thereof |
| 01/18/2012 | CN101921481B Gel prepared by in situ crosslinking hyaluronic acid and polyaspartic acid and preparation method thereof |
| 01/18/2012 | CN101884623B Levodopa methyl ester slow-release microsphere composition and preparation method thereof |
| 01/18/2012 | CN101884622B Benserazide sustained-release microspherical composition and preparation method thereof |
| 01/18/2012 | CN101838466B Preparation for feather keratin membrane and use of feather keratin membrane as medicament carrier |
| 01/18/2012 | CN101797387B Magnetic targeting carrier capable of carrying gene and drug, preparation method and application thereof |
| 01/18/2012 | CN101721684B Immunowakeup microsystem as well as preparation method and application thereof |
| 01/18/2012 | CN101695487B Polyenoic ethyl ester emulsion of high-purity EPA-E and DHA-E |
| 01/18/2012 | CN101695478B Tamsulosin hydrochloride sustained-release pellets and preparation method thereof |
| 01/18/2012 | CN101607080B Oral drug for treating diabetes and preparation method thereof |
| 01/18/2012 | CN101569615B Film coating agent used for exudative solid preparation and method for preparing same |
| 01/18/2012 | CN101530387B An oral intake slowback pharmaceutic preparation |
| 01/18/2012 | CN101410098B Microspheres comprising nanocapsules containing a lipophilicdrug |
| 01/18/2012 | CN101322755B Medicament composition, external-use paste and preparation thereof |
| 01/18/2012 | CN101239180B Complexes for target killing tumor cell, preparation and application thereof |
| 01/18/2012 | CN101035512B Pharmaceutical compositions for controlled release delivery of biologically active compounds |
| 01/17/2012 | US8097702 Cytokine polypeptide for use in treatment and prevention of viral and cell proliferative disorders |
| 01/17/2012 | US8097698 Derivatives of GLP-1 analogs |
| 01/17/2012 | US8097695 Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof |
| 01/17/2012 | US8097653 Dosage unit comprising a prostaglandin analog for treating constipation |
| 01/17/2012 | US8097649 Composition and method for stabilizing the same |
| 01/17/2012 | US8097642 Therapeutic inhibitor of vascular smooth muscle cells |
| 01/17/2012 | US8097607 loading-dose regimen; an initial administration of rifalazil for 4 to 14 days, followed by less than half this average daily dose for the subsequent 4 to 14 days |
| 01/17/2012 | US8097600 Method of increasing tear production with purinergic receptor agonists |
| 01/17/2012 | US8097405 Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs |
| 01/17/2012 | US8097343 Functionalized dendritic polymers for the capture and neutralization of biological and chemical agents |
| 01/17/2012 | US8097279 Chewable soft capsule |
| 01/17/2012 | US8097277 Charge-dynamic polymers and delivery of anionic compounds |
| 01/17/2012 | US8097275 External skin patch |
| 01/17/2012 | US8097274 Skin substitutes, preparation methods and uses thereof |
| 01/17/2012 | US8097271 Warming compositions and delivery systems therefor |
| 01/17/2012 | US8097262 Gel type enteral nutrient |
| 01/17/2012 | US8097252 Methods and compositions for administering therapeutic and diagnostic agents |
| 01/17/2012 | US8097248 Mite composition, use thereof, method for rearing the phytoseiid predatory mite Amblyseius sirskii, rearing system for rearing said phytoseiid mite and methods for biological pest control on a crop |
| 01/17/2012 | US8097247 Probiotic, lactic acid-producing bacteria and uses thereof |
| 01/17/2012 | US8097236 The invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable |
| 01/17/2012 | CA2561361C Crosslinkable pressure-sensitive adhesive for the skin |
| 01/17/2012 | CA2519711C Implantable medical device with beneficial agent concentration gradient |
| 01/17/2012 | CA2489010C Bisacyloxypropylcysteine conjugates and their use |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |
| 01/17/2012 | CA2484640C Vitamin-mitomycin conjugates |
| 01/17/2012 | CA2451353C Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/17/2012 | CA2429998C Intraocular implants for preventing transplant rejection in the eye |
| 01/17/2012 | CA2379180C Methods for suppressing appetite and enhancing exercise and recovery |
| 01/17/2012 | CA2264191C Recombinant toxin fragments |
| 01/12/2012 | WO2012006635A1 Processable single chain molecules and polypeptides made using same |
| 01/12/2012 | WO2012006398A2 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 01/12/2012 | WO2012006397A2 Antiperspirant products comprising natural phospholipids and methods for manufacturing the same |
| 01/12/2012 | WO2012006395A1 Respiratory syncytial virus antigenic compositions and methods |
| 01/12/2012 | WO2012006101A2 Blood substitutes and uses thereof |
| 01/12/2012 | WO2012006083A2 Targeted receptor-mediated sirna |
| 01/12/2012 | WO2012005376A1 Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
| 01/12/2012 | WO2012005365A1 Particle coating preparation |
| 01/12/2012 | WO2012005359A1 Orally disintegrating tablet |
| 01/12/2012 | WO2012005340A1 Tablet containing ferric citrate |
| 01/12/2012 | WO2012005311A1 Composition for contact lens care |
| 01/12/2012 | WO2012004610A1 Delivery of hydrophilic peptides |
| 01/12/2012 | WO2012004402A1 Process for preparation of polymer body |
| 01/12/2012 | WO2012004399A1 Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis |
| 01/12/2012 | WO2012004369A1 Immunomodulatory protein constructs with a helical polymeric backbone |
| 01/12/2012 | WO2012004308A1 Stable aqueous formulations comprising poorly water soluble active ingredients |
| 01/12/2012 | WO2012004009A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | WO2012004008A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | WO2012004007A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | WO2012004006A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | WO2012004005A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | WO2012004004A1 Nitric oxide delivering hydroxyalkyl starch derivatives |
| 01/12/2012 | WO2012003704A1 Sodium alginate crosslinked slow-released moxiflorxacin microsphere, the preparation method and the use thereof, and target vascular occlusive agent of the microsphere |
| 01/12/2012 | WO2012003563A1 Antineoplastic pharmaceutical compositions containing substituted nitroaromatic compounds |
| 01/12/2012 | WO2012003562A1 Antineoplastic pharmaceutical compositions containing substituted nitroimidazoles |
| 01/12/2012 | WO2011145077A3 Branched polypeptides and their use in promoting adhesion of cells to solid surfaces |
| 01/12/2012 | WO2011139420A3 Propynylaminoindan transdermal compositions |
| 01/12/2012 | WO2011118958A3 Oil-in-water type nano-emulsion composition and method for preparing same |
| 01/12/2012 | WO2011112900A3 Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 01/12/2012 | WO2011112793A3 Non-aqueous structured compositions |
| 01/12/2012 | WO2011112700A3 Poly(ester amide) macromers and polymers thereof |
| 01/12/2012 | WO2011110407A3 Micelle compositions and process for the preparation thereof |
| 01/12/2012 | WO2011108882A3 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 01/12/2012 | WO2011105835A3 Method and apparatus for preparing novel liposome |
| 01/12/2012 | WO2011068872A3 Carboxyvinyl polymer-containing nanoparticle suspension |